Literature DB >> 10559267

One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element.

E C Thornborrow1, J J Manfredi.   

Abstract

Key to the function of the tumor suppressor p53 is its ability to activate the transcription of its target genes, including those that encode the cyclin-dependent kinase inhibitor p21 and the proapoptotic Bax protein. In contrast to Saos-2 cells in which p53 activated both the p21 and bax promoters, in MDA-MB-453 cells p53 activated the p21 promoter, but failed to activate the bax promoter. Neither phosphorylation of p53 on serines 315 or 392 nor an intact C terminus was required for p53-dependent activation of the bax promoter, demonstrating that this differential regulation of bax could not be explained solely by modifications of these residues. Further, this effect was not due to either p73 or other identified cellular factors competing with p53 for binding to its response element in the bax promoter. p53 expressed in MDA-MB-453 cells also failed to activate transcription through the p53 response element of the bax promoter in isolation, demonstrating that the defect is at the level of the interaction between p53 and its response element. In contrast to other p53 target genes, like p21, in which p53-dependent transcriptional activation is mediated by a response element containing two consensus p53 half-sites, activation by p53 of the bax element was mediated by a cooperative interaction of three adjacent half-sites. In addition, the interaction of p53 with its response element from the bax promoter, as compared with its interaction with its element from the p21 promoter, involves a conformationally distinct form of the protein. Together, these data suggest a potential mechanism for the differential regulation of p53-dependent transactivation of the bax and p21 genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559267     DOI: 10.1074/jbc.274.47.33747

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.

Authors:  C Perez-Sanchez; V S Budhram-Mahadeo; D S Latchman
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

2.  Activity of the Ste20-like kinase, SLK, is enhanced by homodimerization.

Authors:  Sierra Delarosa; Julie Guillemette; Joan Papillon; Ying-Shan Han; Arnold S Kristof; Andrey V Cybulsky
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-15

3.  A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs.

Authors:  Grégoire Stik; Sylvie Laurent; Damien Coupeau; Baptiste Coutaud; Ginette Dambrine; Denis Rasschaert; Benoît Muylkens
Journal:  RNA       Date:  2010-09-29       Impact factor: 4.942

4.  Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277.

Authors:  Jiri Buzek; Leena Latonen; Sari Kurki; Karita Peltonen; Marikki Laiho
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

5.  Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest.

Authors:  Fan Zhang; Wei Wang; Yoshiaki Tsuji; Suzy V Torti; Frank M Torti
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

6.  Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis.

Authors:  Asima Bhattacharyya; Ranajoy Chattopadhyay; Brent R Burnette; Janet V Cross; Sankar Mitra; Peter B Ernst; Kishor K Bhakat; Sheila E Crowe
Journal:  Gastroenterology       Date:  2009-06       Impact factor: 22.682

7.  Hypoxia-induced decrease in p53 protein level and increase in c-jun DNA binding activity results in cancer cell resistance to etoposide.

Authors:  Jean-Philippe Cosse; Marie Ronvaux; Noëlle Ninane; Martine J Raes; Carine Michiels
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

8.  Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Authors:  Alberto Inga; Francesca Storici; Thomas A Darden; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  A p53-Pax2 pathway in kidney development: implications for nephrogenesis.

Authors:  Zubaida Saifudeen; Jiao Liu; Susana Dipp; Xiao Yao; Yuwen Li; Nathaniel McLaughlin; Karam Aboudehen; Samir S El-Dahr
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.